163 related articles for article (PubMed ID: 11554591)
21. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
[TBL] [Abstract][Full Text] [Related]
22. Experience with prophylaxis in Sweden.
Nilsson IM
Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
[No Abstract] [Full Text] [Related]
23. Update on treatment regimens: prophylaxis versus on-demand therapy.
Manco-Johnson MJ
Semin Hematol; 2003 Jul; 40(3 Suppl 3):3-9. PubMed ID: 14690062
[TBL] [Abstract][Full Text] [Related]
24. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
den Uijl IE; Fischer K
Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430
[No Abstract] [Full Text] [Related]
25. Prevention of arthropathy in haemophilia: prophylaxis.
Santagostino E; Mancuso ME
Haemophilia; 2008 Nov; 14 Suppl 6():16-9. PubMed ID: 19134028
[TBL] [Abstract][Full Text] [Related]
26. [New viewpoints in the treatment of hemophilia].
Göbel U
Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
[No Abstract] [Full Text] [Related]
27. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
[TBL] [Abstract][Full Text] [Related]
28. Arthropathy and substitution therapy.
Aledort LM
Haemostasis; 1992; 22(5):245-6. PubMed ID: 1478534
[No Abstract] [Full Text] [Related]
29. Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.
Feldman BM; Pai M; Rivard GE; Israels S; Poon MC; Demers C; Robinson S; Luke KH; Wu JK; Gill K; Lillicrap D; Babyn P; McLimont M; Blanchette VS;
J Thromb Haemost; 2006 Jun; 4(6):1228-36. PubMed ID: 16706965
[TBL] [Abstract][Full Text] [Related]
30. Experience of prophylaxis treatment in children with severe haemophilia.
Yee TT; Beeton K; Griffioen A; Harrington C; Miners A; Lee CA; Brown SA
Haemophilia; 2002 Mar; 8(2):76-82. PubMed ID: 11952841
[TBL] [Abstract][Full Text] [Related]
31. Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study.
Hilliard P; Zourikian N; Blanchette V; Chan A; Elliott B; Israels SJ; Nilson J; Poon MC; Laferriere N; Van Neste C; Jarock C; Wu J; McLimont M; Feldman B
J Thromb Haemost; 2013 Mar; 11(3):460-6. PubMed ID: 23301594
[TBL] [Abstract][Full Text] [Related]
32. Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s.
Fischer K; Steen Carlsson K; Petrini P; Holmström M; Ljung R; van den Berg HM; Berntorp E
Blood; 2013 Aug; 122(7):1129-36. PubMed ID: 23777770
[TBL] [Abstract][Full Text] [Related]
33. Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs.
Tagliaferri A; Rivolta GF; Rossetti G; Pattacini C; Gandini G; Franchini M
Thromb Haemost; 2006 Oct; 96(4):542-3. PubMed ID: 17003937
[No Abstract] [Full Text] [Related]
34. Unresolved issues in prophylaxis.
Brown SA; Aledort LM; Astermark J; Berntorp E; van den Berg M; Blanchette V; Donfield S; Gringeri A; Hilgartner M; Kulkarni R; Leissinger C; Negrier C; Nuss R; Petterson H; Petrini P; Poulios N; Schramm W;
Haemophilia; 2002 Nov; 8(6):817-21. PubMed ID: 12410654
[No Abstract] [Full Text] [Related]
35. Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.
Rossbach HC
Vasc Health Risk Manag; 2010 Mar; 6():59-68. PubMed ID: 20234780
[TBL] [Abstract][Full Text] [Related]
36. Central venous access devices in children with hemophilia: an update.
Blanchette VS; Al-Musa A; Stain AM; Ingram J; Fille RM
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S11-4. PubMed ID: 9351530
[TBL] [Abstract][Full Text] [Related]
37. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Manco-Johnson MJ; Abshire TC; Shapiro AD; Riske B; Hacker MR; Kilcoyne R; Ingram JD; Manco-Johnson ML; Funk S; Jacobson L; Valentino LA; Hoots WK; Buchanan GR; DiMichele D; Recht M; Brown D; Leissinger C; Bleak S; Cohen A; Mathew P; Matsunaga A; Medeiros D; Nugent D; Thomas GA; Thompson AA; McRedmond K; Soucie JM; Austin H; Evatt BL
N Engl J Med; 2007 Aug; 357(6):535-44. PubMed ID: 17687129
[TBL] [Abstract][Full Text] [Related]
38. Therapy for AHF and PTC hemophilia. II.
Seeler RA
IMJ Ill Med J; 1970 Jun; 137(6):598-602 passim. PubMed ID: 4393113
[No Abstract] [Full Text] [Related]
39. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study.
Tagliaferri A; Feola G; Molinari AC; Santoro C; Rivolta GF; Cultrera DB; Gagliano F; Zanon E; Mancuso ME; Valdré L; Mameli L; Amoresano S; Mathew P; Coppola A;
Thromb Haemost; 2015 Jul; 114(1):35-45. PubMed ID: 25855376
[TBL] [Abstract][Full Text] [Related]
40. Haemophilia prophylaxis: a model and future directions in Jordan.
Awidi A; Faouri S; Kiswani BA; Al-Sweedan S; Albarqawi M; Bsoul N; Haddadin I; Al-Falah M; Telfah A; Hermans C
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s343-4. PubMed ID: 24120588
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
